Portuguese researchers identified a type of immune cell that appears to travel to the pancreas to stimulate glucagon ...

The two companies will work together on Zealand’s amylin analogue petrelintide as a monotherapy and in combination therapies.

Highmark cited exorbitant drug costs, higher medical utilization and sicker patients remaining in its Medicaid business for fueling fiscal pressures.

GLP-1 receptor agonists (GLP-1RAs) were initially approved for diabetes treatment (e.g., Ozempic®) but have revolutionized weight management ...

Fatty pancreas disease, characterized by intra-pancreatic fat deposition, is more prevalent than diabetes, pancreatitis, and ...

Beyond type 2 diabetes and weight loss, GLP-1 agonists can also help lower blood pressure, improve lipid disorders, reduce ...

As health care costs continue to rise and the burden of chronic disease grows, data-driven insights will be essential in ...

A typical CGM detects glucose levels in the interstitial fluid with an enzyme-based sensor. The sensor converts glucose ...

More than 830 million people worldwide have diabetes—a chronic, debilitating disease. But experts say it’s possible to ...

The company’s weight loss therapy was able to sustain itself for up to 40 days in obese patients after a single injection.

Like so many issues in life, taking a short walk or spin on your bike, can provide some relief when it comes to food noise.

According to nutritionist Ángela Quintas it all comes down to what you’re eating—and, more specifically, how it impacts your ...